Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Scarfi MR et al. | 1999 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz | 0.05–1 mT |
Del Re B et al. | 2004 | bacterium, <i>Escherichia coli</i>/Lac Z<sup>-</sup> strain (transformed with a plasmid containing a Tn10 derivative element expressing beta-galactosidase only after transposition)) | magnetic field, low frequency, 50/60 Hz | 0.05–1 mT |
Capri M et al. | 2004 | intact cell/cell culture, human peripheral blood mononuclear cells | magnetic field, 50/60 Hz, co-exposure | 0.05–2.5 mT |
Tokalov SV et al. | 2003 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 60 µT |
Tonini R et al. | 2001 | intact cell/cell culture, NG108-15 cells (the cells result from the fusion of N18TG-2 mouse neuroblastoma cells with C6BU-1 rat glioma cells) | magnetic field, 50/60 Hz | 60–360 µT |
Katsir G et al. | 1998 | intact cell/cell culture, primary chick embryo fibroblasts | magnetic field, low frequency, 50/60 Hz, co-exposure | 0.06–0.7 mT |
Van Den Heuvel R et al. | 2001 | intact cell/cell culture, 3T3 cells (mouse fibroblasts) and mouse bone marrow cells | magnetic field, 50/60 Hz | 80 µT |
Tao Q et al. | 1999 | intact cell/cell culture, HL-60 (human acute myeloid leukaemia cells) | magnetic field, 50/60 Hz, co-exposure | 100 µT |
Phillips JL et al. | 1986 | intact cell/cell culture, human colon carcinoma cell line (Colo 205 and Colo 320 DM) | electric field, magnetic field, 50/60 Hz | 100 µT |
Cain CD et al. | 1993 | intact cell/cell culture, C3H 10T1/2 and UV/TDT10e (10e) cells (mouse fibroblast cells) | magnetic field, 50/60 Hz, co-exposure | 0.1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.